Muscular Dystrophy UK

[NAME] MP House of Commons London SW1A 0AA . Dear [NAME] Re: Access to spinal muscular atrophy treatment called Spinraza . I am writing to you regarding access to the new spinal muscular atrophy (SMA) treatment called Spinraza and the heart-breaking news in August 2018 that NICE’s first guidance is not to recommend Spinraza for use on the NHS in England. ................
................